{"id":"W2745668487","doi":"10.1016/s1470-2045(17)30576-4","title":"Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Astex Pharmaceuticals","keywords":"Medicine; Myeloid leukaemia; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000999634,0.0004447099,0.001759893,0.0001668354,0.0003878445,0.00007844487,0.0008291398,0.0003517267,0.000197712],"category_scores_gemma":[0.001875887,0.0002512029,0.0001732636,0.0001730366,0.0006131557,0.0002292709,0.0002231073,0.0008769841,0.0001677629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001831149,"about_ca_system_score_gemma":0.001140067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002088347,"about_ca_topic_score_gemma":0.001090448,"domain_scores_codex":[0.9963411,0.0005990194,0.0007810821,0.0007623364,0.000510317,0.001006157],"domain_scores_gemma":[0.9951888,0.001597174,0.0006637366,0.002019039,0.0002194065,0.0003118527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9331591,0.004629975,0.002053884,0.00001028045,0.000880783,0.0017657,0.001883192,0.000004075106,0.001153256,0.00001485579,0.006274053,0.04817088],"study_design_scores_gemma":[0.9462946,0.01280926,0.005321898,0.00007860585,0.0007107223,0.00003092072,0.0001875049,0.0007928487,0.001124965,0.00005871138,0.03233556,0.0002544014],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750162,0.00009999566,0.00002942236,0.01153272,0.0004381517,0.005128404,0.0009883792,0.00007213162,0.006694553],"genre_scores_gemma":[0.9910443,0.0007453865,0.001441954,0.0009127414,0.002253677,0.0005733758,0.001124537,0.00006977726,0.001834226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04791647,"threshold_uncertainty_score":0.999994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05811141162999822,"score_gpt":0.3966105076241037,"score_spread":0.3384990959941055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}